Wakako Maruyama

Mitochondrial Genome Variation in Eastern Asia and the Peopling of Japan

Masashi Tanaka, Vicente M. Cabrera, Ana González et al. · Genome Research · 2004 · 528 citations · Full text

Life Sciences, Biology, Genetics +17

Gene Therapy for Mitochondrial Disease by Delivering Restriction Endonuclease <i>Sma</i>I into Mitochondria

Masashi Tanaka, Harm-Jan Borgeld, Jin Zhang et al. · Journal of Biomedical Science · 2002 · 211 citations

Life Sciences, Genetics, Molecular Biology +12

Transfection‐enforced Bcl‐2 overexpression and an anti‐Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde‐3‐phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, <i>N</i>‐methyl(<i>R</i>)salsolinol

Wakako Maruyama, Yukihiro Akao, Moussa B. H. Youdim et al. · Journal of Neurochemistry · 2001 · 168 citations

Life Sciences, Cell Biology, Pharmacology +17

Mitochondrial permeability transition mediates apoptosis induced by <i>N</i>‐methyl(<i>R</i>)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, <i>N</i>‐propargyl‐1(<i>R</i>)‐aminoindan

Yukihiro Akao, Wakako Maruyama, Shigeomi Shimizu et al. · Journal of Neurochemistry · 2002 · 165 citations

Life Sciences, Neuroscience, Pharmacology +13

Gene therapy for mitochondrial disease by delivering restriction endonucleaseSmaI into mitochondria

Masashi Tanaka, Harm-Jan Borgeld, Jin Zhang et al. · Journal of Biomedical Science · 2002 · 161 citations

Life Sciences, Genetics, Molecular Biology +12